Ginsenoside Rb1 and paeoniflorin inhibit transient receptor potential vanilloid-1-activated IL-8 and PGE2 production in a human keratinocyte cell line HaCaT

International Immunopharmacology

Volumn 10, Issue 10, 2010, Pages 1279-1283

  Huang, Jin ^a   Qiu, Lei ^b   Ding, Li ^b   Wang, Shaozhan ^b   Wang, Jing ^b   Zhu, Quangang ^a   Song, Fengyu ^c   Hu, Jinhong ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c INDIANA UNIVERSITY SCHOOL OF DENTISTRY   (United States)

Author keywords

Ginsenoside Rb1; HaCaT cell; IL 8; Paeoniflorin; PGE2; TRPV1

Indexed keywords

CAPSAICIN; CAPSAZEPINE; GINSENOSIDE RB 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PAEONIFLORIN; PROSTAGLANDIN E2; VANILLOID RECEPTOR 1;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL STRAIN HEK293; CHINESE HERB; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFICACY; DRUG INHIBITION; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN INFLAMMATION; TREATMENT RESPONSE; WESTERN BLOTTING;

BENZOIC ACIDS; BRIDGED COMPOUNDS; CELL LINE; GENE EXPRESSION REGULATION; GINSENOSIDES; GLUCOSIDES; HUMANS; INTERLEUKIN-8; KERATINOCYTES; NF-KAPPA B; TRPV CATION CHANNELS;

EID: 77957239722     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.07.010     Document Type: Article

References (29)

1. Yamahara J., Yamada T., Kimura H., Sawada T., Fujimura H. Biologically active principles of crude drugs. II. Anti-allergic principles in "Shoseiryu-To" anti-inflammatory properties of paeoniflorin and its derivatives. J Pharmacobiodyn 1982, 5:921-929.
2. Sun Y., Dong Y., Jiang H.J., Cai T.T., Chen L., Zhou X., et al. Dissection of the role of paeoniflorin in the traditional Chinese medicinal formula Si-Ni-San against contact dermatitis in mice. Life Sci 2009, 84:337-344.
3. Hsu F.L., Lai C.W., Cheng J.T. Antihyperglycemic effects of paeoniflorin and 8-debenzoylpaeoniflorin, glucosides from the root of Paeonia lactiflora. Planta Med 1997, 63:323-325.
4. Sugishita E., Amagaya S., Ogihara Y. Studies on the combination of Glycyrrhizae Radix in Shakuyakukanzo-To. J Pharmacobiodyn 1984, 7:427-435.
5. Liu D.Z., Xie K.Q., Ji X.Q., Ye Y., Jiang C.L., Zhu X.Z. Neuroprotective effect of paeoniflorin on cerebral ischemic rat by activating adenosine A1 receptor in a manner different from its classical agonists. Br J Pharmacol 2005, 146:604-611.
6. Lee J.H., Kim S.R., Bae C.S., Kim D., Hong H., Nah S. Protective effect of ginsenosides, active ingredients of Panax ginseng, on kainic acid-induced neurotoxicity in rat hippocampus. Neurosci Lett 2002, 325:129-133.
7. Lee E., Kim S., Chung K.C., Choo M.K., Kim D.H., Nam G., et al. 20(S)-ginsenoside Rh2, a newly identified active ingredient of ginseng, inhibits NMDA receptors in cultured rat hippocampal neurons. Eur J Pharmacol 2006, 536:69-77.
8. Rhim H., Kim H., Lee D.Y., Oh T.H., Nah S.Y. Ginseng and ginsenoside Rg3, a newly identified active ingredient of ginseng, modulate Ca2+ channel currents in rat sensory neurons. Eur J Pharmacol 2002, 436:151-158.
9. Tsai T.Y., Wu S.N., Liu Y.C., Wu A.Z., Tsai Y.C. Inhibitory action of L-type Ca2+ current by paeoniflorin, a major constituent of peony root, in NG108-15 neuronal cells. Eur J Pharmacol 2005, 523:16-24.
10. Alappatt C., Johnson C.A., Clay K.L., Travers J.B. Acute keratinocyte damage stimulates platelet-activating factor production. Arch Dermatol Res 2000, 292:256-259.
11. Kemeny L., Kenderessy A.S., Olasz E., Michel G., Ruzicka T., Farkas B., et al. The interleukin-8 receptor: a potential target for antipsoriatic therapy Eur J Pharmacol 1994, 258:269-272.
12. Kim M.S., Lim W.K., Park R.K., Shin T., Yoo Y.H., Hong S.H., et al. Involvement of mitogen-activated protein kinase and NF-kappaB activation in Ca2+-induced IL-8 production in human mast cells. Cytokine 2005, 32:226-233.
13. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389:816-824.
14. Hayes P., Meadows H.J., Gunthorpe M.J., Harries M.H., Duckworth D.M., Cairns W., et al. Cloning and functional expression of a human orthologue of rat vanilloid receptor-1. Pain 2000, 88:205-215.
15. Davis J.B., Gray J., Gunthorpe M.J., Hatcher J.P., Davey P.T., Overend P., et al. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 2000, 405:183-187.
16. Southall M.D., Li T., Gharibova L.S., Pei Y., Nicol G.D., Travers J.B. Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. J Pharmacol Exp Ther 2003, 304:217-222.
17. Seki N., Shirasaki H., Kikuchi M., Himi T. Capsaicin induces the production of IL-6 in human upper respiratory epithelial cells. Life Sci 2007, 80:1592-1597.
18. Lee L.Y., Gu Q. Role of TRPV1 in inflammation-induced airway hypersensitivity. Curr Opin Pharmacol 2009, 9:243-249.
19. Banvolgyi A., Palinkas L., Berki T., Clark N., Grant A.D., Helyes Z., et al. Evidence for a novel protective role of the vanilloid TRPV1 receptor in a cutaneous contact allergic dermatitis model. J Neuroimmunol 2005, 169:86-96.
20. Amadesi S., Nie J., Vergnolle N., Cottrell G.S., Grady E.F., Trevisani M., et al. Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J Neurosci 2004, 24:4300-4312.
21. Bergmans A.M., Coenen J.L., Bakhuizen R., Mooi B.W., Ramdat Misier A.R., Wilbrink B., et al. Endocarditis in a Dutch patient caused by Bartonella quintana. Clin Microbiol Infect 1997, 3:692-695.
22. Kim H.A., Kim S., Chang S.H., Hwang H.J., Choi Y.N. Anti-arthritic effect of ginsenoside Rb1 on collagen induced arthritis in mice. Int Immunopharmacol 2007, 7:1286-1291.
23. Kawahira K., Sumiyoshi M., Sakanaka M., Kimura Y. Effects of ginsenoside Rb1 at low doses on histamine, substance P, and monocyte chemoattractant protein 1 in the burn wound areas during the process of acute burn wound repair. J Ethnopharmacol 2008, 117:278-284.
24. Biro T., Acs G., Acs P., Modarres S., Blumberg P.M. Recent advances in understanding of vanilloid receptors: a therapeutic target for treatment of pain and inflammation in skin. J Investig Dermatol Symp Proc 1997, 2:56-60.
25. Wu H., Li W., Wang T., Shu Y., Liu P. Paeoniflorin suppress NF-kappaB activation through modulation of I kappaB alpha and enhances 5-fluorouracil-induced apoptosis in human gastric carcinoma cells. Biomed Pharmacother 2008, 62:659-666.
26. Ma W., Quirion R. Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain. Expert Opin Ther Targets 2007, 11:307-320.
27. Pal M., Angaru S., Kodimuthali A., Dhingra N. Vanilloid receptor antagonists: emerging class of novel anti-inflammatory agents for pain management. Curr Pharm Des 2009, 15:1008-1026.
28. Gunthorpe M.J., Chizh B.A. Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway. Drug Discov Today 2009, 14:56-67.
29. Khairatkar-Joshi N., Szallasi A. TRPV1 antagonists: the challenges for therapeutic targeting. Trends Mol Med 2009, 15:14-22.